1.26 USD
▲+0.09+7.69%
盘后 1.30 +3.17%
2026-11-20
市值
$8.69M
市盈率
—
EPS
-3.55
股息率
—
52 周区间
1.00 – 36.00
成交量
91.27K
Beta
1.22
目标价
42.00
52W 低 1.0052W 高 36.00
价格走势
公司简介
CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. The company also develops Auxora for the treatment of ulcerative colitis, traumati...